COMMUNITY-BASED STUDY OF THYROID DYSFUNCTION AND MENSTRUAL IRREGULARITIES IN REPRODUCTIVE-AGE WOMEN AND ITS TREATMENT
Main Article Content
Keywords
Thyroid dysfunction, menstrual irregularities, subclinical hypothyroidism, reproductive age, community-based study
Abstract
Background: The hypothalamic-pituitary-ovarian axis is an important regulator of the menstrual cycle and it is influenced by thyroid hormones. Thyroid disease is a frequent but underdiagnosed disorder in women of reproductive age and commonly is linked to menstrual dysfunction.
Objective: To determine the frequency of thyroid dysfunction and its association with menstrual irregularities among reproductive-age women in a community-based setting.
Methods: This cross-sectional study was a community-based study in January 2024 to January 2025 at Pak International Medical College Peshawar. A sample of 72 women aged 1845 years was taken through non-probability consecutive sampling. A structured questionnaire was used to collect data on demographic characteristics, menstrual history and clinical features. ELISA was used to determine the levels of thyroid functions such as serum TSH, FT3, and FT4. Data analysis was done using SPSS version 25. Associations were evaluated using Chi-square test at p 0.05 which was regarded as statistically significant.
Results: The mean age of participants was 29.8 ± 6.4 years. Thyroid dysfunction was observed in 47.2% of participants, while 58.3% reported menstrual irregularities. Subclinical hypothyroidism was the most common thyroid disorder (25.0%). A significantly higher proportion of women with thyroid dysfunction had irregular menstrual cycles (61.9%) compared to euthyroid women (38.1%) (p = 0.003).
Conclusion: Thyroid dysfunction is highly prevalent among reproductive-age women and is significantly associated with menstrual irregularities. Routine screening and early management of thyroid disorders may improve menstrual health and reproductive outcomes.
References
2. He Y, Zheng D, Shang W, Wang X, Zhao S, Wei Z, et al. Prevalence of oligomenorrhea among women of childbearing age in China: A large community-based study. 2020;16:1745506520928617.
3. Mahboobifard F, Rahmati M, Amiri M, Azizi F, Tehrani FRJAiMS. To what extent does polycystic ovary syndrome influence the cut-off value of prolactin? Findings of a community-based study. 2022;67(1):79-86.
4. Thong EP, Milat F, Joham AE, Mishra GD, Teede HJCe. Obesity, menstrual irregularity and polycystic ovary syndrome in young women with type 1 diabetes: A population‐based study. 2020;93(5):564-71.
5. Patel S, Pushpalatha K, Singh B, Shrisvastava R, Singh G, Dabar DJTSWJ. Evaluation of hormonal profile and ovarian morphology among adolescent girls with menstrual irregularities in a tertiary care centre at central India. 2022;2022(1):3047526.
6. Ezhumalai G, Sundaram MM, Meenakumari RJJoS. A STUDY ON MENSTRUAL PROBLEMS AMONG UNMARRIED HOSTELERS–AN OBSERVATIONAL STUDY (COMMUNITY BASED): MENSTRUAL PROBLEMS. 2021;5(1):14-8.
7. Bogale B, Wolde A, Mohammed N, Midaksa G, Bekele BBJFiP. Poor sleep quality and factors among reproductive-age women in Southwest Ethiopia. 2022;13:913821.
8. Gerema U, Kene K, Abera D, Adugna T, Nigussie M, Dereje D, et al. Abnormal uterine bleeding and associated factors among reproductive age women in Jimma town, Oromia Region, Southwest Ethiopia. 2022;18:17455057221077577.
9. Ganie MA, Rashid A, Sahu D, Nisar S, Wani IA, Khan JJIJoG, et al. Prevalence of polycystic ovary syndrome (PCOS) among reproductive age women from Kashmir valley: A cross‐sectional study. 2020;149(2):231-6.
10. Zhong Y, Peng S, Chen Q, Huang D, Zhang G, Zhou ZJF, et al. Preconceptional thyroid stimulating hormone level and fecundity: a community-based cohort study of time to pregnancy. 2023;119(2):313-21.
11. Sharmila SJEE. Reproductive Health Status of Rural Women in Coimbatore District, Tamil Nadu. 2020;11(10):50.
12. Rojhani E, Rahmati M, Firouzi F, Saei Ghare Naz M, Azizi F, Ramezani Tehrani FJD. Polycystic ovary syndrome, subclinical hypothyroidism, the cut-off value of thyroid stimulating hormone; is there a link? Findings of a population-based study. 2023;13(2):316.
13. Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, et al. Polycystic ovary syndrome. 2022;10(9):668-80.
14. van der Ham K, Stekelenburg KJ, Louwers YV, van Dorp W, Schreurs MW, van der Wal R, et al. The prevalence of thyroid dysfunction and hyperprolactinemia in women with PCOS. 2023;14:1245106.
15. Makwe CC, Olamijulo JA, Balogun MR, Akinkugbe AO, Samuel A, Udenze K, et al. SAT363 the prevalence and phenotype of polycystic ovary syndrome (PCOS) in A Community-Based population in Sub-Sahara Africa: the Nigeria-PEP study. 2023;7(Supplement_1):bvad114. 1668.
16. Dosiou CJT. Thyroid and fertility: recent advances. 2020;30(4):479-86.
17. Sharma VK, Niraula A, Tuladhar ET, Bhattarai A, Raut M, Dubey RK, et al. Autoimmune thyroid status in subclinical thyroid disorders in patients attending a tertiary care center in Nepal: a hospital-based cross-sectional study. 2023;23(1):221.
18. Varghese L, Saji A, Bose PJIJoR, Contraception, Obstetrics, Gynecology. Menstrual irregularities and related risk factors among adolescent girls. 2022;11(8):2159.
19. Behboudi‐Gandevani S, Amiri M, Cheraghi L, Amanollahi Soudmand S, Azizi F, Ramezani Tehrani FJCE. The risk of chronic kidney disease among women with polycystic ovary syndrome: A long‐term population‐based cohort study. 2020;93(5):590-7.
20. Xu H, Feng G, Alpadi K, Han Y, Yang R, Chen L, et al. A model for predicting polycystic ovary syndrome using serum AMH, menstrual cycle length, body mass index and serum androstenedione in Chinese reproductive aged population: A retrospective cohort study. 2022;13:821368.

